An optical lattice with single lattice site optical control for quantum engineering

2000 ◽  
Vol 2 (5) ◽  
pp. 645-650 ◽  
Author(s):  
R Scheunemann ◽  
F S Cataliotti ◽  
T W Hänsch ◽  
M Weitz
2013 ◽  
Vol 88 (1) ◽  
Author(s):  
Joanna Pietraszewicz ◽  
Tomasz Sowiński ◽  
Mirosław Brewczyk ◽  
Maciej Lewenstein ◽  
Mariusz Gajda

2006 ◽  
Vol 97 (12) ◽  
Author(s):  
B. Sun ◽  
W. X. Zhang ◽  
S. Yi ◽  
M. S. Chapman ◽  
L. You

1997 ◽  
Vol 44 (10) ◽  
pp. 1853-1862
Author(s):  
A. GORLITZ , T. HANSCH and A. HEMMERIC

Author(s):  
D. Fontani ◽  
P. Sansoni ◽  
S. Coraggia ◽  
L. Mercatelli ◽  
D. Jafrancesco ◽  
...  
Keyword(s):  

Author(s):  
Martin Reynders ◽  
Bryan Matsuura ◽  
Marleen Bérouti ◽  
Daniele Simoneschi ◽  
Antonio Marzio ◽  
...  

<p><i>PROTACs (proteolysis targeting chimeras) are bifunctional molecules that tag proteins for ubiquitylation by an E3 ligase complex and subsequent degradation by the proteasome. They have emerged as powerful tools to control the levels of specific cellular proteins and are on the verge of being clinically used. We now introduce photoswitchable PROTACs that can be activated with the temporal and spatial precision that light provides. These trifunctional molecules, which we named PHOTACs, consist of a ligand for an E3 ligase, a photoswitch, and a ligand for a protein of interest. We demonstrate this concept by using PHOTACs that target either BET family proteins (BRD2,3,4) or FKBP12. Our lead compounds display little or no activity in the dark but can be reversibly activated to varying degrees with different wavelengths of light. Our modular and generalizable approach provides a method for the optical control of protein levels with photopharmacology and could lead to new types of precision therapeutics that avoid undesired systemic toxicity.</i><b></b></p>


Sign in / Sign up

Export Citation Format

Share Document